Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Collection Of Blood Samples

Research Leaders

6 sponsors active, led by Ain Shams University

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Unknown2
Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Collection Of Blood Samples1
  • Chemotherapy Drugs1
  • Lactoferrin Iron And B12 In Whey Protein1
  • Targeted Drugs1
  • Pd1 And Pdl1 Inhibitor1

Active Sponsors

  • Ain Shams University1
  • Utah State University1
  • Glanbia Nutritionals1
  • Metromol SA1
  • Tianjin Medical University Cancer Institute and Hospital1

Top Investigators

Related Conditions

  • Betathalassemia1
  • Iron Chelation Therapy1
  • Acute Leukemia1
  • Malignant Solid Tumors1
  • Immunerelated Adverse Event1

Activity Timeline